OKYO Pharma (OKYO) Operating Leases (2021)
OKYO Pharma's (OKYO) quarterly Operating Leases came in at $98760.0 in Q1 2021.
Powered by 
Analysis
OKYO Pharma (OKYO) Operating Leases (2021) Analysis & Trends
OKYO Pharma (OKYO) has reported Operating Leases for 1 consecutive years, with $98760.0 the latest figure, recorded in Q1 2021.
- On a quarterly basis, Operating Leases changed N/A year-over-year to $98760.0 in Q1 2021; TTM through Mar 2021 was $98760.0, a N/A change from a year earlier, with the FY2021 full-year figure at $98760.0, changed N/A from the prior year.
- Operating Leases was $98760.0 for Q1 2021 at OKYO Pharma.
- Over five years, Operating Leases peaked at $98760.0 in Q1 2021 and troughed at $98760.0 in Q1 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.67 Bn | 192.69 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.06 Bn | 176.88 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 131.44 Bn | 123.59 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.94 Bn | 73.95 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.28 Bn | 55.10 Bn | 1.37 Bn |
| 6 | Moderna | 53.87 Bn | 48.73 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.15 Bn | 29.85 Bn | 992.69 Mn |
| 8 | Biogen | 31.88 Bn | 30.60 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.16 Bn | 29.16 Bn | 1.16 Mn |
| 10 | OKYO Pharma | 962.06 Mn | 962.06 Mn | - |